Objective. The objective of the study was to see if transforaminal injection of steroids might be an effective treatment for persistent radicular pain after disc surgery.
Introduction
Although surgical decompression is the mainstay of treatment for lumbar radicular pain, pain may persist or recur despite well-indicated and well-performed surgery [1] [2] [3] . For patients with persistent or recurrent radicular pain, treatment options are few [4] .
Transforaminal injection of steroids (TFIS) is a specific treatment for lumbar radicular pain, but to date, has been studied only in patients who have not undergone surgery. Whereas some studies found no evidence of efficacy [5] [6] [7] , others found some [8] or strong evidence [9] [10] [11] [12] for both short-and long-term relief. The effectiveness of TFIS in patients who have not been relieved by surgery is not known.
The present study was undertaken to determine if TFIS might be an effective option in patients with persistent pain after surgery. It involved a retrospective audit of the author's personal experience.
Methods
An electronic medical record system was used to identify all patients in a single spine center who had undergone microsurgical lumbar disc surgery, at one or two levels, for lumbar radicular pain. In all cases, the ligamentum flavum was dissected without removal of any bone or with very little removal of the lamina. Patients who had undergone laminectomy or other types of operation were excluded, as were patients with a history of prior lumbar disc surgery.
Every patient was seen 1 month after the operation for follow-up. Further follow-up was conducted according to the complaints of the patient. In patients with persisting pain, a distinction was strictly made between nonradiating pain and radicular pain. Only patients with persistent radicular pain were included in the present study.
These patients were treated in an interventional pain management ambulatory surgery center, with a transforaminal injection of triamcinolone (10 mg) and bupivacaine (0.25%), at the level and side of operation. The injections were performed under fluoroscopic guidance using established techniques [13] . A subpedicular approach to the "safe-triangle" was used [13] .
The primary outcome measure was percentage reduction in pain. The secondary outcome was duration of relief. A successful response to treatment was defined as at least 50% reduction of pain persisting for longer than 3 months. Associations between a successful response and features on magnetic resonance imaging (MRI) were explored. Significance was tested using a chi-squared test.
Results
Between January 2007 and December 2008, microdiscectomy was performed on 297 men and 182 women. Of these, 60.5% required no further treatment. Of the patients with persistent pain, 120 (25.1%) had predominantly back pain without radicular pain. Of the 69 patients with persistent radicular pain, 56 had pain that lasted beyond 3 months, and were treated with TFIS. No adverse effects were encountered. Table 1 presents their demographic and clinical features.
As shown in Figure 1 , only 15 patients (27%) reported greater than 50% reduction in pain, for periods ranging between 4 and 34 months (with a mean of 15.5 months). Nine patients with a positive response from TFIS, but with relief for less than 3 month were rated as unsuccessfully treated.
Despite good reduction in pain, an MRI was obtained in 11 of these 15 patients. One had a recurrent disc herniation, and one had a herniation at a different level. MRI was performed also in 37 of the 41 patients who did not respond to TFIS. Of these, 24 (58.5%) had a recurrent disc herniation, and two had a herniation at a different level.
A good result after TFIS occurred significantly more often in patients without a recurrent herniation on MRI (Table 2) . In those patients, the success rate of TFIS was 43.5%. Successful outcomes tended to be more common (10/24; 42%) if patients were treated within 2 months after surgery than if patients were treated at 3 months or later (5/32; 16%), but the difference between these two proportions falls short of being statistically significant.
Discussion
The present study was not undertaken to test the effectiveness or efficacy of TFIS. It was deliberately an exploratory study, for which purpose a practice audit is a reasonable method. It sought to see if TFIS might be a reasonable intervention for persistent radicular pain after microdiscectomy.
Although a recently published algorithm for the treatment of patients with failed back surgery syndrome recommends therapeutic injections [4], evidence for their effectiveness is very limited. On transforaminal injections, the literature is limited to two studies, published in 1998 and 1999, in which less than one-third of patients treated with nerve root sleeve injections of steroids obtained greater than 50% relief of pain at 6 months follow-up [14, 15] . This is consonant with the success rate of 27% in the present study.
The success rate was significantly greater (43%) in patients who did not have a recurrent disc herniation. This is consistent with the observations of Ghahreman and Bogduk [16] who found that a favorable response to TFIS was associated with lower grades of nerve compression. The association suggests that TFIS might be more useful in postsurgical patients in whom radicular inflammation is the cause of persistent pain, than in patients with other causes.
Success rates of 27% or even 43% may not be impressive, but they apply to a condition for which there is no proven treatment. From a pragmatic perspective, physicians might care to afford their patients a one in four chance of benefiting from TFIS. From a scientific perspective, however, these low success rates need to be distinguished from placebo responses. Chi-squared = 10.6; P = 0.001. MRI, magnetic resonance imaging; TFIS, transforaminal injection of steroids.
